We are live on ! Find out more
VTYX

Ventyx Biosciences
VTYX

Delisted

VTYX was delisted on the 3rd of March, 2026.

Back to rankings

1 hedge funds and large institutions have $21K invested in Ventyx Biosciences in 2026 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 138 closing their positions.

New
Increased
Maintained
Reduced
Closed

73.19% less ownership

Funds ownership: 73.19% → 0% (-73%)

99% less funds holding

Funds holding: 139 → 1 (-138)

99% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 138

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

100% less capital invested

Capital invested by funds: $472M → $21K (-$472M)

Holders
1
Holders Change
-138
Holders Change %
-99.28%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
138
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
IA
IFP Advisors
Florida
+$20.3K

Top Sellers

Rank Fund Capital Flow
1
AAA
Affinity Asset Advisors
New York
-$58.6M
2
Morgan Stanley
Morgan Stanley
New York
-$38.8M
3
BlackRock
BlackRock
New York
-$28.4M
4
TCM
Tang Capital Management
California
-$25.4M
5
BBA
Baker Bros. Advisors
New York
-$21.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
T. Rowe Price Associates
76
T. Rowe Price Associates
Maryland
– -$307K -33,977 Closed
Commonwealth Equity Services
77
Commonwealth Equity Services
Massachusetts
– -$295K -32,630 Closed
VIA
78
Virtus Investment Advisers
Connecticut
– -$293K -32,483 Closed
GCM
79
Graham Capital Management
Connecticut
– -$292K -32,381 Closed
FRM
80
Fox Run Management
Connecticut
– -$292K -32,361 Closed
QC
81
Quadrature Capital
United Kingdom
– -$284K -31,501 Closed
CS
82
Cannell & Spears
New York
– -$280K -31,000 Closed
Man Group
83
Man Group
United Kingdom
– -$258K -28,621 Closed
AIP
84
Arrowpoint Investment Partners
Singapore
– -$257K -28,453 Closed
Envestnet Asset Management
85
Envestnet Asset Management
Illinois
– -$255K -28,229 Closed
OAC
86
OMERS Administration Corp
Ontario, Canada
– -$237K -26,200 Closed
AQR Capital Management
87
AQR Capital Management
Connecticut
– -$233K -25,768 Closed
JFG
88
Jefferies Financial Group
New York
– -$214K -23,750 Closed
AG
89
Algert Global
California
– -$208K -23,050 Closed
CUAMC
90
China Universal Asset Management Company
China
– -$195K -21,628 Closed
Bank of Nova Scotia
91
Bank of Nova Scotia
Ontario, Canada
– -$176K -19,534 Closed
EC
92
EntryPoint Capital
New York
– -$160K -17,708 Closed
VOYA Investment Management
93
VOYA Investment Management
Georgia
– -$158K -17,475 Closed
JGC
94
J. Goldman & Co
New York
– -$157K -17,406 Closed
Bank of New York Mellon
95
Bank of New York Mellon
New York
– -$132K -14,638 Closed
PA
96
Profund Advisors
Maryland
– -$131K -14,560 Closed
Rafferty Asset Management
97
Rafferty Asset Management
New York
– -$123K -13,638 Closed
SRL
98
Scientech Research LLC
New Jersey
– -$119K -13,174 Closed
LIP
99
Lighthouse Investment Partners
Florida
– -$114K -12,660 Closed
ET
100
Entropy Technologies
New York
– -$105K -11,663 Closed
2 3
4
5 6

VTYX Hedge Fund Activity: Q1 2026 in Review

1 of the 8,127 institutional investors tracked by Wall St. Rank reported a position in Ventyx Biosciences (VTYX) for Q1 2026, worth a combined $21K — down 100% from $472M a quarter earlier.

Sellers outnumbered buyers: 138 funds closed out of VTYX and 1 opened new positions — a net loss of 137 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was IFP Advisors, opening a new position worth an estimated $20.3K. The largest seller was Affinity Asset Advisors, exiting entirely with an estimated $58.6M sold.

  • 1 institutional investor held Ventyx Biosciences (VTYX) as of Q1 2026, down from 139 in Q4 2025.
  • Funds reported $21K of Ventyx Biosciences stock for Q1 2026, down 100% quarter-over-quarter.
  • 1 fund opened new Ventyx Biosciences positions in Q1 2026 and 138 closed out, a net change of -137 holders.
  • The largest Ventyx Biosciences buyer in Q1 2026 was IFP Advisors, an estimated $20.3K added.
  • The largest Ventyx Biosciences seller in Q1 2026 was Affinity Asset Advisors, an estimated $58.6M sold.

Based on aggregated 13F filings for Q1 2026.